Introduction
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor cytokine superfamily and has a homotrimeric structure. Since TRAIL induces apoptosis in a variety of transformed and cancer cells, but not in normal cells, it is a promising target for cancer prevention and treatment. However, growing evidence suggests that some cancer cell types such as malignant melanoma, glioma and non-small cell lung cancer (NSCLC) cells are resistant to TRAIL-induced apoptosis (1) . Moreover, TRAIL-responsive tumors acquire a resistant phenotype that renders TRAIL therapy ineffective. Overcoming the TRAIL resistance of cancer cells is necessary for effective TRAIL therapy and drugs potentiating TRAIL effectiveness are urgently required (2) . TRAIL binds to receptors (DRs) that contain death domains such as death receptor (DR) 4/TRAIL-receptor 1 (TRAIL-R1) and DR5/TRAIL-R2 (3). This binding induces oligomerization of the receptors and conformational changes in the death domains, resulting in the formation of a death-inducing signaling complex; and subsequent activation of caspase-8. In turn, activated caspase-8 activates the effector caspase-3/6/7, which executes the apoptotic process (4, 5) . The activation of caspase-8 is also linked to the intrinsic (mitochondrial) apoptotic pathway. Activated caspase-8 can cleave and activate the pro-apoptotic Bcl-2-family molecule Bid, which in turn activates other Bcl-2-family molecules, Bax and Bak, resulting in their oligomerization and the formation of megachannels in the outer mitochondrial membrane. The release of cytochrome c through the Bax/Bak megachannels into the cytosol induces the assembly of apoptosome and the activation of caspase-9, resulting in the activation of caspase-3/6/7 (4) . Recently, various pro-apoptotic receptor agonists such as recombinant human TRAIL and agonistic antibodies against DR4/DR5 have been subjected to clinical trials in a variety of cancer cell types, including malignant melanoma and NSCLC cells. Unfortunately, the results showed that these receptor agonists were disappointedly only modestly effective (6) . Induction of apoptosis by the intrinsic pathway is considered to be the major mechanism of conventional chemotherapy and is therefore a critical target in cancer treatment. However, clinical observations suggest that amplification of the known apoptotic pathways is not sufficient for overcoming TRAIL resistance in cancer cells. ) , and hydroxyl radicals (•OH) are products of normal metabolism in virtually all aerobic organisms and are also produced following xenobiotic exposure. Low physiological levels of ROS function as second messengers in intracellular signaling and are required for normal cell function, while excessive ROS cause damage to multiple macromolecules, impair cell function, and promote cell death (7) . Imbalance between ROS production and the ability of a biological system to detoxify oxidants or to repair the resulting damage leads to oxidative stress. Several lines of evidence suggest that intracellular H 2 O 2 is a mediator of DR ligand-induced apoptosis in tumor cells. The flavonoid wogonin kills TNF-α-resistant T-cell leukemia cells and sensitizes them to TNF-α-or TRAIL-induced apoptosis by increasing intracellular H 2 O 2 levels (8). LY303511 sensitizes human neuroblastoma cells to TRAIL, and intracellular H 2 O 2 generation plays a role in this effect (9) . On the other hand, some evidence suggests that H 2 O 2 acts as an anti-apoptotic factor in DR ligand-induced apoptosis. The continuous presence of low concentrations of H 2 O 2 inhibits caspase-mediated apoptosis in Jurkat cells by inactivating pro-caspase-9 (10). It was reported that in human astrocytoma cells, H 2 O 2 is generated in a caspase-dependent manner and contributes to resistance to TRAIL-induced apoptosis (11) . Thus, the role of H 2 O 2 in DR ligand-induced apoptosis is controversial.
Hydrogen peroxide induces cell death in human TRAIL
Here we demonstrate that H 2 O 2 induces cell death in TRAIL-resistant melanoma cells via intracellular O 2 -generation. Our data suggest that the intracellular O 2 -mediates ER-associated cell death in these cells. Importantly, normal primary melanocytes were much lesser sensitive than malignant melanoma cells to oxidative cell death.
Materials and methods

Chemicals and antibodies.
Reagents were obtained from the following manufacturers: soluble recombinant human TRAIL, Enzo Life Sciences (San Diego, CA); DATS, Wako Pure Chemicals (Osaka, Japan); thapsigargin, Sigma-Aldrich (St. Louis, MO); z-VAD-fluoromethylketone (fmk) (VAD), z-DEVD-fmk (DEVD), z-IETD-fmk (IETD), z-LETD-fmk (LETD) and Mn (III) tetrakis (4-benzonic acid) porphyrin chloride (MnTBaP), Calbiochem (La Jolla, CA). z-LEVD-fmk (LEVD) and z-ATAD-fmk (ATAD), BioVision (Mountain View, CA); dichlorohydrofluorescein diacetate (DCFH-DA), dihydroethidium (DHE), MitoSOX™ Red (MitoSOX) and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benz-imidazolocarbocyamine iodide (JC-1), Life Technologies Japan (Tokyo, Japan). Reagents were dissolved in dimethylsulfoxide and diluted with Hanks' balanced salt solution (HBSS; pH 7.4) to a final concentration of <0.1% before use. Dimethylsulfoxide alone at a concentration of 0.1% (vehicle) showed no effects throughout this study. Polyclonal antibodies against X-box-binding protein-1 (XBP-1) and glucose-related protein 78 (GRP78) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). All the other chemicals were of analytical grade.
Cell culture. Human A2058 and SK-MEL-2 melanoma cells were obtained from Health Science Research Resource Bank (Osaka, Japan). Human A375 melanoma cells were obtained from American Type Culture Collection (Manassas, VA). These cells were cultured in high glucose-containing Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS) in a 5% CO 2 -containing atmosphere. The cells were harvested by incubation in 0.25% trypsin-EDTA medium (Life Technologies Japan) for 5 min at 37˚C. Normal human epidermal melanocytes were obtained from Cascade Biologics (Portland, OR) and cultured in DermaLife Basal medium (Kurabo, Osaka, Japan) supplemented with DermaLife M LifeFactors (Kurabo) in a 5% CO 2 -containing atmosphere. The cells were harvested by incubation in 0.25% trypsin-EDTA medium for 5 min at 37˚C.
Determination of cell death by fluorescence microscopy. The overall cell death was evaluated by performing fluorescence microscopy as previously described (12) . Briefly, the cells (1x10 4 cells) were placed on 8-chamber coverslips (Asahi Glass Co., Tokyo, Japan) and treated with the agents to be tested for 24 h at 37˚C in a 5% CO 2 -containing atmosphere. The cells were then stained with 4 µM each of calcein-AM and ethidium bromide homodimer-1 (EthD-1) to label live and dead cells, respectively, using a commercially available kit (LIVE/DEAD ® Viability/ Cytotoxicity kit; Life Technologies Japan) according to the manufacturer's instructions. Images were obtained using a fluorescence microscope (IX71 inverted microscope, Olympus, Tokyo, Japan) and analyzed using the LuminaVision software (Mitani Corporation, Fukui, Japan).
Determination of apoptotic cell death. Apoptotic cell death was quantitatively assessed as previously described (12) . Briefly, the cells plated in 24-well plates (2x10 5 cells/well) were treated with TRAIL and the agents to be tested alone or together for 20 h in DMEM containing 10% FBS (FBS/DMEM). Subsequently, the cells were stained with FITC-conjugated Annexin V and PI using a commercially available kit (Annexin V FITC Apoptosis Detection Kit I; BD Biosciences, San Jose, CA). The stained cells were analyzed in a FACSCalibur flow cytometer (BD Biosciences) using the CellQuest software (BD Biosciences 
Measurements of mitochondrial membrane potential (∆Ψ m )
depolarization and caspase-3/7 activation. ∆Ψ m depolarization and caspase-3/7 activation were simultaneously measured by a previously described method (12) . Briefly, the cells plated in 24-well plates (2x10 5 cells/well) were treated with the agents to be tested in FBS/DMEM for 24 h, stained with the dual sensor MitoCasp (Cell Technology Inc., Mountain View, CA), and analyzed for their caspase-3/7 activity and ∆Ψ m in the FACSCalibur using the CellQuest software. Changes in ∆Ψ m were also measured using the lipophilic cation JC-1 by a previously described method (13) .
Measurement of caspase-12 activation.
Activated caspase-12 in living cells was detected using the caspase-12 inhibitor ATAD conjugated to FITC as previously described (12) . This compound binds to active caspase-12, but not to inactive caspase-12. The cells (2x10 5 cells/ml) were stained with FITC-ATAD for 30 min at 37˚C using a CaspGLOW Fluorescein Caspase-12 Staining Kit (BioVision) according to the manufacturer's protocol. Fluorescence was determined using the FL-1 channel of the FACSCalibur and analyzed using the CellQuest software.
Measurement of intracellular ROS.
The production of intracellular ROS was measured using the oxidation sensitive DHE and DCFH-DA by flow cytometry by a previously described method (14) . Briefly, cells (4x10 5 /500 µl) resuspended in HBSS were treated with the agents to be tested and incubated at 37˚C for various time periods, then incubated with 5 µM DHE or DCFH-DA for 15 min at 37˚C. The cells were washed, resuspended in HBSS on ice and centrifuged at 4˚C. The green fluorescence (DCFH-DA) and red fluorescence (DHE) were measured using the FL-1 and FL-2 channels of the FACSCalibur, respectively, and analyzed using the CellQuest software. Mitochondrial O 2 -generation was measured using the mitochondria-targeting probe MitoSOX Red as previously described (14) . Briefly, the cells (4x10 5 /500 µl) suspended in HBSS were treated with the agents to be tested and incubated at 37˚C for various time periods, then incubated with 5 µM MitoSOX Red for 15 min at 37˚C. The cells were washed, resuspended in HBSS on ice, and centrifuged at 4˚C. The red fluorescence was measured using the FL-2 channels of the FACSCalibur and analyzed by CellQuest software.
Detection of intercellular ROS by fluorescent microscopy.
The cells (1x10 4 ) were plated on 8-chamber cover glasses and treated with the agents to be tested for 30 min at 37˚C in a 5% CO 2 containing atmosphere. After removal of the medium, the cells were stained with 4 µM each of DCFH-DA and DHE to label cells producing H 2 O 2 and O 2 -, respectively. Images were obtained with the fluorescence microscope and analyzed using LuminaVision software.
Western blot analysis. Western blot analysis was carried out by the previously described method (12) . The cells in 6-well plates (1x10 6 cells/ml/well) were treated with the agents to be tested for 24 h at 37˚C, washed and lysed with SDS-sample buffer. The whole cell lysates were subjected to SDS-PAGE and transferred to PVDF membranes (Nippon Millipore, Tokyo, Japan). After blocking the membranes with BlockAce (Dainippon Sumitomo Pharma, Osaka, Japan) at room temperature for 60 min, GRP78 and XBP-1 proteins on the membranes were detected using specific antibodies. Antibody-antigen complexes were detected using the ECL Prime Western Blotting Reagent (GE Healthcare Japan, Tokyo, Japan). To verify equal loading, the membranes were re-probed with an antibody against β-actin or GAPDH. (Fig. 1B and C) . In addition, more pronounced cell death was observed in the cells treated with TRAIL and H 2 O 2 than in the cells treated with either of the agents alone. The cytotoxic effects of H 2 O 2 on TRAIL-resistant melanoma cells were confirmed by apoptosis measurements using Annexin V/PI staining. H 2 O 2 treatment resulted in a dose-and time-dependent increase in apoptosis in the A375 cells ( Fig. 1D and E -induced cell death, we examined whether or not the cell death was caspase-dependent. Analysis using caspase-specific inhibitors revealed that H 2 O 2 -induced apoptosis exhibited discriminate sensitivities to the given caspase inhibitor depending on the concentration of the oxidant applied. The general caspase inhibitor VAD pronouncedly inhibited the apoptosis induced by 30 µM H 2 O 2 (maximum of 63% inhibition), while the caspase-3/7 inhibitor DEVD reduced it by 40% ( Fig. 2A) . Strikingly, the caspase-12 inhibitor ATAD was as effective as VAD and was significantly more effective than DEVD at inhibiting apoptosis. By contrast, the caspase-4 inhibitor LEVD enhanced rather than suppressed apoptosis. Interestingly, all these inhibitors minimally inhibited the apoptosis induced by 100 µM H 2 O 2 (Fig. 2B) . We further examined the effects of H 2 O 2 on the ∆Ψ m and caspase-3/7 activation, as these are hallmarks of the intrinsic apoptotic pathway. Flow cytometric analysis using the fluorescent ∆Ψ m -sensitive dye or the caspase-3/7-specific probe revealed that H 2 O 2 induced ∆Ψ m depolarization and caspase-3/7 activation in a dose-dependent manner (Fig. 2C and D ). These data show that H 2 O 2 stimulates multiple death pathways including intrinsic apoptotic and caspase-independent apoptotic and necrotic death pathways, depending on the concentration applied. Fig. 3A , only a modest increase in DCF (green) fluorescence, but not DHE (red) fluorescence, was observed in TRAIL-treated cells. This increase in DCF fluorescence was transient and declined to below the basal level within 1 h. On the other hand, unexpectedly, H 2 O 2 treatment increased not only DCF fluorescence but also DHE fluorescence, indicating the production of intracellular O 2 -. This oxidative response was confirmed by flow cytometric analysis. The increase in the DHE signal was initially observed at 1 h (Fig. 3B) , and it lasted for at least 4 h; the signal was completely abolished by superoxide dismutase (SOD) mimetic antioxidant MnTBaP (Fig. 3C) .
Results
H 2 O 2 induces cell death in human TRAIL
Because mitochondria are the major site of ROS generation under physiological conditions, we examined the role of this organelle in H 2 O 2 -induced O 2 -generation. MitoSOX localizes to the mitochondria and serves as a fluoroprobe for selective detection of O 2 -in the organelle (15, 19) . As shown in Fig. 3D , a substantial increase in the MitoSOX signal was initially observed at 1 h after treatment and the increase lasted for at least 4 h; again, MnTBaP completely abolished the effect (Fig. 3E) . Similar effects were also observed in A2058 cells (data not shown). To understand the role of intracellular O 2 -in H 2 O 2 -induced cell death, we examined the effect of MnTBaP treatment on cell death. The antioxidant blocked apoptosis in a dose-dependent manner (Fig. 3F) . In addition to apoptosis, necrotic cell death induced by 100 µM H 2 O 2 was also reduced. On the contrary, catalase had no effect on the cell death (data not shown). Fig. 4A and B) . Furthermore, To obtain further evidence for the induction of ER stress, we assessed the levels of 2 unfolded protein response (UPR) proteins GRP78 and XBP-1, after H 2 O 2 treatment. Western blot analysis showed that treatment with the positive control thapsigargin considerably upregulated the expression of GRP78 for 24 h, while H 2 O 2 treatment did not (Fig. 4D) . On the other hand, H 2 O 2 increased the expression of XBP-1, although the degree varied considerably in different experiments. Both the active spliced form (XBP-1s) and inactive unspliced form (XBP-1u) of XBP-1 were increased, and these effects were totally inhibited by MnTBaP treatment (Fig. 4E) primary normal melanocytes. Fluorescence microscopic analysis revealed that treatment with 100 ng/ml TRAIL and 100 µM H 2 O 2 alone or in combination for 24 h resulted in minimal cell death (data not shown) and apoptosis (Fig. 5A ) in normal melanocytes. In addition, only minimal intracellular and mitochondrial O 2 -generation was observed after 4-h H 2 O 2 treatment ( Fig. 5B and C) . These data indicate that melanocytes are resistant to H 2 O 2 -induced cell death and O 2 -generation.
Discussion
In the present study, we investigated the induced apoptotic or necrotic cell death, depending on the concentration of the oxidant applied. The intrinsic mitochondrial pathway is considered to be the major mechanism of apoptosis. Consistent with this view, the cell death induced by low concentrations of H 2 O 2 was caspase-dependent and was associated with increased ∆Ψ m collapse and caspase-3/7 activation. However, inhibition of caspase-3/7 only partially blocked apoptosis. These data suggest that while the intrinsic mitochondrial pathway does play a role in inducing apoptosis, another caspase cascade may also be involved in this caspase-dependent apoptosis. ER can initiate cell death through a pathway that is independent of intrinsic (mitochondria) and extrinsic (death receptor) pathways. ER-associated cell death is thought to be mediated by caspase-12 (22) (23) (24) (25) (26) . A variety of cellular conditions such as glucose deprivation, hypoxia, disturbance of calcium homeostasis and excess ROS can cause ER stress, which is characterized by the accumulation of unfolded proteins. ER stress activates the adaptive UPR, which protects cells owing to protein synthesis inhibition, chaperone protein upregulation and an increase in protein degradation. If UPR activation is not able to relieve ER stress, the cells undergo ER-mediated apoptosis (22) (23) (24) (25) (26) . Upon ER stress, the chaperone molecule GRP78 dissociates from the transmembrane proteins, such as inositol requiring enzyme 1α (IRE1α) and activating transcription factor 6 (ATF6). The free ATF6 translocates to the Golgi apparatus where it is activated. The active ATF6 in turn enters the nucleus and initiates the expression of the transcription factor XBP-1. Activated IRE1α splices the transcribed XBP-1 mRNA to allow translation of the mature XBP-1 protein, which acts as a transcription factor and mediates the transcriptional upregulation of numerous genes involved in ER function (20, 21, 23 Interestingly, while activation of caspase-12 following the induction of ER stress during apoptosis has been reported in various mammalian cells including mouse, rat, rabbit and cow (26) , the role of caspase-12 in ER-mediated apoptosis of human cells is a matter of debate. This might be because the human caspase-12 gene contains several mutations that block its expression (27) . Nevertheless, an increasing body of evidence suggests that a caspase-12-like protein exists and is activated in human cells following the induction of ER stress by divergent causes, including H 2 O 2 , cisplatin, tetrocarcin A and hyperthermia (12, (28) (29) (30) (31) (32) (33) .
Recently, adaptation to ER stress was suggested to be a key driver of malignancy and resistance to therapy in cancer cells, including malignant melanoma cells, with GRP78 playing a key role in this adaptation (34, 35) . GRP78 expression is associated with tumor development and growth and is correlated with resistance to chemotherapeutic drugs such as cisplatin and adriamycin (34) (35) (36) . In this study, thapsigargin substantially increased GRP78 expression, while H 2 O 2 decreased GRP78 expression in melanoma cells; these cells were killed by H 2 O 2 , but not thapsigargin. On the other hand, GRP78 expression was minimally increased in thapsigargin-sensitive Jurkat leukemia cells (Inoue and Suzuki, unpublished data) . GRP78 has been shown to exert its anti-apoptotic function by inhibiting caspase-4 or caspase-7 activity (36). However, caspase-4 appears to regulate H 2 O 2 -induced apoptosis negatively rather than positively, as inhibition of the enzymatic activity significantly enhanced the apoptosis. Given the structural similarity between caspase-4 and caspase-12, it is possible that GRP78 may also target caspase-12 to counteract ER-mediated apoptosis.
ROS levels are controlled by the antioxidant defense system, including the antioxidant enzymes manganese-or copper-zinc-containing superoxide dismutase, which catalyze the dismutation of O 
